PR Newswire Asia's news > Infectious Disease Control

 |   Detail   |   Print    Next page > 
     
Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)
2026-07-27T    Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
PUBLIC TRUST IN HEALTH INNOVATION IS SHAPED MORE BY MINDSET THAN DEMOGRAPHICS, DNV RESEARCH FINDS
2026-07-23T    Biotechnology   Health Care/Hospital   Infectious Disease Control 
GHIT Fund Invests Approx. JPY 140 Million in a Portable Rapid Diagnostic System for Ebola Disease in a Joint Project Between Osaka Metropolitan University, K.K. DNAFORM, and INRB
2026-07-23T    Banking/Financial Service   Biotechnology   Health Care/Hospital   Infectious Disease Control 
Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing
2026-07-15T    Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
MASSPHOTON Launches the Industry's First 200 LPM UVC LED Water Disinfection System, Independently Certified for High-Flow Applications
2026-06-30T    Computer/Electronics   Infectious Disease Control 
Six Regional Organisations Sign MoU to Strengthen Asia's Dengue Response as Cases Rise
2026-06-15T    Education   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development
2026-06-09T    Biotechnology   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
Duke-NUS awarded €2 million EU grant to help Asia detect outbreaks earlier through wastewater surveillance
2026-06-09T    Education   Health Care/Hospital   Higher Education   Infectious Disease Control 
Ebola disease in Democratic Republic of Congo: MSF scales up response to a rapidly evolving outbreak
2026-06-01T    Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
WuXi Vaccines' Drug Substance Facility Receives Brazil ANVISA GMP Certification for Dengue Vaccine Manufacturing
2026-05-26T    Biotechnology   Health Care/Hospital   Infectious Disease Control   Medical/Pharmaceuticals 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.